Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments

Overview of attention for article published in Multiple Sclerosis Journal – Experimental, Translational and Clinical, June 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 6 X users

reddit: 2 Redditors

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 7,951 followers.

RT @MSJ_Research: Tumefactive demyelination in the course of #Multiplesclerosis: Clinical outcomes, lesion evolution and treatments https:…

Tumefactive MS may predict a more benign overall course and is susceptible to traditional immunomodulatory treatments ! Interesting #multiplesclerosis #ms https://t.co/hOH2OY6sEF https://t.co/7VdmPlUfBy

RT @MSJ_Research: Tumefactive demyelination in the course of #Multiplesclerosis: Clinical outcomes, lesion evolution and treatments https:…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.